When epithelial cells in lung cancer sputum samples were selectively captured by microdissection, the sensitivity for the detection of mutations in TP53 and KRAS increased about three times (∼46%) compared to using the entire sputum cells [79]. The gene discussed is KRAS; the disease is lung carcinoma.